Worldwide, a growing number of people are using self-care products to prevent or treat common ailments and dietary supplements to support healthy nutrition. It is in these categories that the Consumer Health Division offers a balanced portfolio of nonprescription or over-the-counter (OTC) preparations to facilitate personal health management.
This portfolio embraces allergy products, analgesics, cardiovascular risk prevention products, cold and flu treatments, dermatology and foot care products, preparations to treat gastrointestinal complaints, dietary supplements and sun protection products. It includes global brands such as Aspirin™, Aleve™, Bepanthen™ / Bepanthol™, Berocca™, Canesten™, Claritin™, Coppertone™, Dr. Scholl’s™, Elevit™, MiraLAX™ and Supradyn™.
Consumer Health can look back on a long tradition in the self-medication market. It began in 1899 with the introduction of Aspirin™, Bayer’s world-renowned iconic brand.
Today, the division operates in more than 100 countries, maintaining 18 production sites and four product research and development centers. Our development strategies are focused on expanding and enhancing our brand portfolio. We aim to achieve this by developing new products along with new delivery forms, formulations, product messages, novel packaging forms and other innovations. We also actively pursue the reclassification of current prescription medicines as OTC products.
Consumer Health aims to build on its strong position to achieve market leadership in the countries and categories in which it operates. Here, the focus is on further integration of the businesses acquired in 2014 from Merck & Co., Inc. in the United States and Dihon Pharmaceutical Group Co., Ltd. in China. We will also pursue any external growth opportunities that arise as the result of ongoing consolidation in the global market for nonprescription products.